261 related articles for article (PubMed ID: 6351057)
41. Comparative effects of a complete tumor promoter, TPA, and a second-stage tumor promoter, RPA, on intercellular communication, cell differentiation and cell transformation.
Yamasaki H; Aguelon-Pegouries AM; Enomoto T; Martel N; Furstenberger G; Marks F
Carcinogenesis; 1985 Aug; 6(8):1173-9. PubMed ID: 3860306
[TBL] [Abstract][Full Text] [Related]
42. Analysis of human promyelocytic leukemia cell (HL60) variants insensitive to phorbol ester tumor promoters.
Mascioli DW; Estensen RD
Cancer Res; 1984 Aug; 44(8):3280-5. PubMed ID: 6331641
[TBL] [Abstract][Full Text] [Related]
43. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
Volpato JP; Fossati E; Pelletier JN
J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
[TBL] [Abstract][Full Text] [Related]
44. Regulation of dihydrofolate reductase synthesis in an overproducing 3T6 cell line during transition from resting to growing state.
Wiedemann LM; Johnson LF
Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2818-22. PubMed ID: 288069
[TBL] [Abstract][Full Text] [Related]
45. The control of phospholipid methylation by phorbol diesters in differentiating human myeloid HL-60 leukemia cells.
Hoffman DR; Huberman E
Carcinogenesis; 1982; 3(8):875-80. PubMed ID: 6812975
[TBL] [Abstract][Full Text] [Related]
46. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate.
James RI; May C; Vagt MD; Studebaker R; McIvor RS
Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973
[TBL] [Abstract][Full Text] [Related]
47. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
[TBL] [Abstract][Full Text] [Related]
48. Stimulation of human polymorphonuclear leukocyte superoxide anion radical production by tumor promoters.
Goldstein BD; Witz G; Amoruso M; Stone DS; Troll W
Cancer Lett; 1981 Jan; 11(3):257-62. PubMed ID: 6265062
[TBL] [Abstract][Full Text] [Related]
49. Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae.
Kündig C; Leblanc E; Papadopoulou B; Ouellette M
Nucleic Acids Res; 1999 Sep; 27(18):3653-9. PubMed ID: 10471733
[TBL] [Abstract][Full Text] [Related]
50. Specific binding of phorbol ester tumor promoters.
Driedger PE; Blumberg PM
Proc Natl Acad Sci U S A; 1980 Jan; 77(1):567-71. PubMed ID: 6965793
[TBL] [Abstract][Full Text] [Related]
51. Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells.
Wani MA; Xu X; Stambrook PJ
Cancer Res; 1994 May; 54(9):2504-8. PubMed ID: 8162600
[TBL] [Abstract][Full Text] [Related]
52. Key determinants in the occurrence of clonal variation in humanized antibody expression of cho cells during dihydrofolate reductase mediated gene amplification.
Kim NS; Byun TH; Lee GM
Biotechnol Prog; 2001; 17(1):69-75. PubMed ID: 11170482
[TBL] [Abstract][Full Text] [Related]
53. In vitro studies on the mode of action of the phorbol esters, potent tumor promoters: part 1.
Blumberg PM
Crit Rev Toxicol; 1980 Dec; 8(2):153-97. PubMed ID: 7002476
[No Abstract] [Full Text] [Related]
54. Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells.
Miyachi H; Jiao L; Sowers LC; Scanlon KJ
In Vivo; 1992; 6(1):17-21. PubMed ID: 1385729
[TBL] [Abstract][Full Text] [Related]
55. Chromosome-mediated transfer and amplification of an altered mouse dihydrofolate reductase gene.
Haber DA; Schimke RT
Somatic Cell Genet; 1982 Jul; 8(4):499-508. PubMed ID: 7123452
[TBL] [Abstract][Full Text] [Related]
56. Specific binding of phorbol ester tumor promoters to intact primary epidermal cells from Sencar mice.
Solanki V; Slaga TJ
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2549-53. PubMed ID: 6941309
[TBL] [Abstract][Full Text] [Related]
57. The effects of tumour promoters on the multiplication and morphology of cultured human epidermal keratinocytes.
Parkinson EK; Emmerson A
Carcinogenesis; 1982; 3(5):525-31. PubMed ID: 6178528
[TBL] [Abstract][Full Text] [Related]
58. DHFR gene amplification in cultured skin fibroblasts of ataxia telangiectasia patients after methotrexate selection.
Lücke-Huhle C; Hinrichs S; Speit G
Carcinogenesis; 1987 Dec; 8(12):1801-6. PubMed ID: 2824082
[TBL] [Abstract][Full Text] [Related]
59. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
Vinh DB; McIvor RS
J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
[TBL] [Abstract][Full Text] [Related]
60. P-glycoprotein confers methotrexate resistance in 3T6 cells with deficient carrier-mediated methotrexate uptake.
de Graaf D; Sharma RC; Mechetner EB; Schimke RT; Roninson IB
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1238-42. PubMed ID: 8577747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
